메뉴 건너뛰기




Volumn 28, Issue 5, 2000, Pages 207-213

Epidemiological aspects of respiratory syncytial virus (RSV) infections in Italy: A national survey

Author keywords

Bronchiolitis; Children; Passive immunoprophylaxis; Pre term babies; Respiratory infections; Respiratory syncytial virus

Indexed keywords

ARTICLE; BRONCHIOLITIS; CHILD; CHILD HOSPITALIZATION; COMORBIDITY; CONGENITAL HEART DISEASE; DISEASE SEVERITY; GEOGRAPHIC DISTRIBUTION; GESTATIONAL AGE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPROPHYLAXIS; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTERVIEW; ITALY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PEDIATRICIAN; PERSISTENT INFECTION; PREMATURITY; QUESTIONNAIRE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SEASONAL VARIATION; VIRUS PNEUMONIA;

EID: 0033762573     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000002800502     Document Type: Article
Times cited : (9)

References (8)
  • 6
    • 0031683919 scopus 로고    scopus 로고
    • The IMPact Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants.
    • (1998) Pediatrics , vol.102 , pp. 531-537
  • 8
    • 0031729747 scopus 로고    scopus 로고
    • American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn: Prevention of respiratory syncytial virus infection: Indications for the use of palivizumab and update on the use of RSV-IGIV
    • (1998) Pediatrics , vol.102 , pp. 1211-1216


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.